MARKET

AVXL

AVXL

Anavex Life Scie
NASDAQ
8.17
+0.05
+0.62%
After Hours: 8.17 0 0.00% 16:20 05/14 EDT
OPEN
8.25
PREV CLOSE
8.12
HIGH
8.56
LOW
8.03
VOLUME
894.01K
TURNOVER
0
52 WEEK HIGH
14.44
52 WEEK LOW
3.510
MARKET CAP
697.49M
P/E (TTM)
-14.7954
1D
5D
1M
3M
1Y
5Y
1D
Anavex Life Sciences: Strategic Opportunities and Financial Stability Drive Buy Rating
TipRanks · 9h ago
Anavex Life Sciences Reports Q2 2025 Financial Results
TipRanks · 16h ago
Anavex Life Sciences Corp reports results for the quarter ended March 31 - Earnings Summary
Reuters · 1d ago
Largest borrow rate increases among liquid names
TipRanks · 1d ago
Anavex reports Q2 EPS (13c) vs. (13c) last year
TipRanks · 1d ago
Anavex sees cash runway of four years
TipRanks · 1d ago
Anavex Life Sciences Corp. Q2 Loss Beats Estimates
NASDAQ · 1d ago
*Anavex Life Sciences Anticipates Runway of About 4 Years at Current Cash Utilization Rates and Ranges >AVXL
Dow Jones · 1d ago
More
About AVXL
More
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with high unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which it uses in the analysis of its clinical trials. Its focus is on developing treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other CNS disorders. It has two core programs and two seed programs. ANAVEX 2-73 is being developed as an oral liquid once-daily formulation for rare diseases such as Rett syndrome as well as an oral once-daily capsule formulation for diseases such as Alzheimer’s disease. ANAVEX 3-71 is a CNS-penetrable potential disease-modifying treatment for cognitive impairments. Its other candidates include ANAVEX 1-41, ANAVEX 1066 and ANAVEX 1037.
Recently
Symbol
Price
%Change

Webull offers Anavex Life Sciences Corp stock information, including NASDAQ: AVXL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVXL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVXL stock methods without spending real money on the virtual paper trading platform.